logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9943522 B1

PDFFull Text
Date of Patent:
Apr. 17, 2018

Filed:

May. 11, 2012

Use of cathepsin k inhibition for the treatment and/or prophylaxis of pulmonary hypertension and/or heart failure

Applicants:

Stefan Golz, Mülheim an der Ruhr, DE;

Martina Delbeck, Heiligenhaus, DE;

Heinrich Meier, Wuppertal, DE;

Andreas Geerts, Wuppertal, DE;

Thomas Mondritzki, Schwelm, DE;

Hubert Trübel, Wuppertal, DE;

Inventors:

Stefan Golz, Mülheim an der Ruhr, DE;

Martina Delbeck, Heiligenhaus, DE;

Heinrich Meier, Wuppertal, DE;

Andreas Geerts, Wuppertal, DE;

Thomas Mondritzki, Schwelm, DE;

Hubert Trübel, Wuppertal, DE;

Assignee:

BAYER INTELLECTUAL PROPERTY GMBH, Monheim, DE;

Attorney:

Morrison & Foerster LLP

Primary Examiner:

San Ming R Hui

Int. Cl.
CPC ...
A61K 31/55 (2006.01); A61K 31/277 (2006.01); A61K 31/336 (2006.01); A61K 31/40 (2006.01); A61K 31/495 (2006.01); A61K 31/165 (2006.01); A61K 31/415 (2006.01); A61K 31/496 (2006.01);
U.S. Cl.
CPC ...
A61K 31/55 (2013.01); A61K 31/165 (2013.01); A61K 31/277 (2013.01); A61K 31/336 (2013.01); A61K 31/40 (2013.01); A61K 31/415 (2013.01); A61K 31/495 (2013.01); A61K 31/496 (2013.01);
Abstract

The present invention relates to the use of cathepsin K and/or cathepsin S inhibitors in a method for the treatment and/or prophylaxis of pulmonary hypertension and/or heart failure.

Find Patent Forward Citations

Golz, Stefan. (2018). Use of cathepsin k inhibition for the treatment and/or prophylaxis of pulmonary hypertension and/or heart failure (U.S. Patent No. 9943522). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/9943522

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…